jump to content jump to footer

Streamline Prostate Cancer Screenings with Prostate.Carcinoma.ai in mint Lesion

The Prostate.Carcinoma.ai plug-in, developed by our partner FUSE-AI, is a powerful addition to mint Lesion, designed specifically to enhance prostate cancer screenings. This advanced solution leverages artificial intelligence to automate and accelerate prostate MR evaluations based on the PI-RADS 2.1 guidelines, transforming the workflow and precision for radiologists.

At the click of a button, Prostate.Carcinoma.ai performs full segmentation of the prostate and its anatomical zones, and detects and segments potentially malignant lesions. mint Lesion maps each finding onto the standardized prostate lesion scheme, eliminating the need for time-consuming manual lesion annotation and drawing.

Radiologists maintain full control over the AI-generated results, with the ability to review, reject, modify, or add new findings to ensure accuracy. Based on these inputs, mint Lesion automatically calculates the PI-RADS score, delivering a comprehensive and structured report.

mint Lesion also enables longitudinal tracking of prostate lesions for MRI-based active surveillance. Radiologists can easily monitor changes in lesions over time, supporting informed decision-making for patient management and enhancing the continuity of care.

mintLesion Prostate Urology AI PI-RADS

Related Resources

Medical professional reviewing patient's MRI images on computer monitor with patient in MRI machine in background.
TGSE-BLADE demonstrated significantly reduced geometric distortion and artifacts caused by intracranial air, enabling more accurate detection of ischemic changes and improving diagnostic confidence in early postoperative MRI.
Postoperative Brain MRI After Tumor Resection: Reducing Artifacts and Improving Diagnostic Accuracy
Postoperative MRI after brain tumor surgery is often affected by artifacts caused by intracranial air, limiting reliable image interpretation. A…
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging
How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?
Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion
Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…